Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature 395, 137-143 (10 September 1998) | doi:10.1038/25931; Received 8 May 1998; Accepted 29 July 1998
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
nature jobs
Senior Lecturer / Reader
- King's College London
- London United Kingdom
Faculty Position - Center for Viral Oncology
- University of Kansas Medical Center
- Kansas City, KS
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-
Robert T. Nolte1,2, G. Bruce Wisely1,2, Stefan Westin3, Jeffery E. Cobb4, Millard H. Lambert1, Riki Kurokawa3, Michael G. Rosenfeld5, Timothy M. Willson4, Christopher K. Glass3 & Michael V. Milburn1
- Department of Structural Chemistry, North Carolina 27709, USA
- Department of Medicinal Chemistry, Division of Chemistry, Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina 27709, USA
- Division of Cellular and Molecular Medicine, San Diego, La Jolla, California 92093-0651, USA
- Howard Hughes Medical Institute, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0651, USA
- These authors contributed equally to this work
Correspondence to: Michael V. Milburn1 Correspondence and requests for materials should be addressed to M.V.M. (e-mail: Email: mvm25452@glaxowellcome.com).Coordinates for the apo-PPAR-
(1PRG) and the PPAR
–rosiglitazone–SRC1 ternary complex (2PRG) have been deposited with the Brookhaven Protein Database.
Abstract
The peroxisome proliferator-activated receptor-
(PPAR-
) is a ligand-dependent transcription factor that is important in adipocyte differentiation and glucose homeostasis and which depends on interactions with co-activators, including steroid receptor co-activating factor-1 (SRC-1). Here we present the X-ray crystal structure of the human apo-PPAR-
ligand-binding domain (LBD), at 2.2 Å resolution; this structure reveals a large binding pocket, which may explain the diversity of ligands for PPAR-
. We also describe the ternary complex containing the PPAR-
LBD, the antidiabetic ligand rosiglitazone (BRL49653), and 88 amino acids of human SRC-1 at 2.3 Å resolution. Glutamate and lysine residues that are highly conserved in LBDs of nuclear receptors form a 'charge clamp' that contacts backbone atoms of the LXXLL helices of SRC-1. These results, together with the observation that two consecutive LXXLL motifs of SRC-1 make identical contacts with both subunits of a PPAR-
homodimer, suggest a general mechanism for the assembly of nuclear receptors with co-activators.
To read this story in full you will need to login or make a payment (see right).

